Efficacy of the use of probiotics based on Lactobacillus spp. in the treatment of recurrent bacterial vaginosis: Systematic Review
DOI:
https://doi.org/10.47187/cssn.Vol15.IssEd.Esp.311Keywords:
Lactobacillus, vaginosis, bacterial, probioticsAbstract
Introduction: Bacterial vaginosis (BV) represents a public health threat, with high incidence and recurrence, affecting women´s quality of life. Restoration of protective Lactobacillus levels using probiotics is an attractive strategy for the management of recurrent BV. Objective: Compare the efficacy of probiotics based on Lactobacillus spp. in the treatment of recurrent BV following antibiotic treatment, in contrast to a placebo control group. Methods: A systematic review of randomized clinical trials (RCTs) was carried out using the Science Direct, PubMed, Cochrane and Google Scholar databases. Results: A total of 7 RCTs that compared various probiotics based on Lactobacillus spp were included in the analysis in patients who have received antibiotic therapy compared to a placebo control group. Discussion: Studies reveal that probiotics with Lactobacillus strains show promise in the treatment and prevention of BV with cure rates similar to control groups, but lower risk of long-term recurrence, and support for their efficacy in vaginal colonization and symptom reduction. Although some trials do not show significant differences, more research is needed regarding their effectiveness and treatment guidelines. Conclusions: The use of probiotics with Lactobacillus is a promising and effective alternative to prevent and treat recurrent BV by helping to restore the balance of the vaginal flora and significantly reducing the risk of recurrence.
Downloads
References
Coudray MS, Madhivanan P. Bacterial vaginosis—A brief synopsis of the literature. European Journal of Obstetrics & Gynecology and Reproductive Biology. el 1 de febrero de 2020;245:143–8.
Merchán K, León AE, Valero N, Quiroz V. Vaginosis bacteriana en mujeres ecuatorianas en edad reproductiva: epidemiologia y efectividad de los criterios diagnósticos. Dominio de las Ciencias. 2020;6(1):236–65.
Brun JL, Castan B, de Barbeyrac B, Cazanave C, Charvériat A, Faure K, et al. Infecciones genitales altas. EMC - Ginecología-Obstetricia. el 1 de septiembre de 2023;59(3):1–15.
Tidbury FD, Langhart A, Weidlinger S, Stute P. Non-antibiotic treatment of bacterial vaginosis—a systematic review. Arch Gynecol Obstet [Internet]. el 1 de enero de 2021 [citado el 20 de noviembre de 2023];303(1):37–45. Disponible en: https://link.springer.com/article/10.1007/s00404-020-05821-x
Zeng X, An R, Li H. Risk factors of recurrent bacterial vaginosis among women of reproductive age: A cross-sectional study. Open Med (Wars) [Internet]. el 1 de enero de 2023 [citado el 7 de enero de 2024];18(1):20230743. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/37588657
Zeng X, An R, Li H. Risk factors of recurrent bacterial vaginosis among women of reproductive age: A cross-sectional study. Open Medicine. el 1 de enero de 2023;18(1).
Reznichenko H, Henyk N, Maliuk V, Khyzhnyak T, Tynna Y, Filipiuk I, et al. Oral Intake of Lactobacilli Can Be Helpful in Symptomatic Bacterial Vaginosis: A Randomized Clinical Study. J Low Genit Tract Dis. el 1 de julio de 2020;24(3):284–9.
Pendharkar S, Skafte-Holm A, Simsek G, Haahr T. Lactobacilli and Their Probiotic Effects in the Vagina of Reproductive Age Women. Microorganisms 2023, Vol 11, Page 636. el 1 de marzo de 2023;11(3):636.
Liu P, Lu Y, Li R, Chen X. Use of probiotic lactobacilli in the treatment of vaginal infections: In vitro and in vivo investigations. Front Cell Infect Microbiol. 2023;13.
Chen X, Lu Y, Chen T, Li R. The Female Vaginal Microbiome in Health and Bacterial Vaginosis. Front Cell Infect Microbiol. el 7 de abril de 2021;11.
Oerlemans EFM, Bellen G, Claes I, Henkens T, Allonsius CN, Wittouck S, et al. Impact of a lactobacilli-containing gel on vulvovaginal candidosis and the vaginal microbiome. Scientific Reports 2020 10:1. el 14 de mayo de 2020;10(1):1–10.
Chee WJY, Chew SY, Than LTL. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microbial Cell Factories 2020 19:1. el 7 de noviembre de 2020;19(1):1–24.
Ellington K, Saccomano SJ. Recurrent bacterial vaginosis. Nurse Pract [Internet]. el 1 de octubre de 2020 [citado el 7 de enero de 2024];45(10):27–32. Disponible en: https://journals.lww.com/10.1097/01.NPR.0000696904.36628.0a
Faught BM, Reyes S. Characterization and Treatment of Recurrent Bacterial Vaginosis. J Womens Health (Larchmt). el 1 de septiembre de 2019;28(9):1218–26.
Sherrard J, Wilson J, Donders G, Mendling W, Jensen JS. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. el 1 de noviembre de 2018;29(13):1258–72.
Lu Y, Aizhan R, Yan H, Li X, Wang X, Yi Y, et al. Characterization, modes of action, and application of a novel broad-spectrum bacteriocin BM1300 produced by Lactobacillus crustorum MN047. Brazilian Journal of Microbiology. el 1 de diciembre de 2020;51(4):2033–48.
Younis N, Mahasneh A. Probiotics and the envisaged role in treating human infertility. Middle East Fertil Soc J. el 1 de diciembre de 2020;25(1):1–9.
Patel M, Siddiqui AJ, Hamadou WS, Surti M, Awadelkareem AM, Ashraf SA, et al. Inhibition of Bacterial Adhesion and Antibiofilm Activities of a Glycolipid Biosurfactant from Lactobacillus rhamnosus with Its Physicochemical and Functional Properties. Antibiotics (Basel). el 1 de diciembre de 2021;10(12).
Russo R, Karadja E, De Seta F. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial. Benef Microbes [Internet]. el 8 de febrero de 2019 [citado el 5 de febrero de 2024];10(1):19–26. Disponible en: https://brill.com/view/journals/bm/10/1/article-p19_3.xml
Park SH, Lee ES, Park ST, Jeong SY, Yun Y, Kim YG, et al. Efficacy and Safety of MED-01 Probiotics on Vaginal Health: A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients [Internet]. el 1 de enero de 2023 [citado el 5 de febrero de 2024];15(2):331. Disponible en: https://www.mdpi.com/2072-6643/15/2/331/htm
Reznichenko H, Henyk N, Maliuk V, Khyzhnyak T, Tynna Y, Filipiuk I, et al. Oral Intake of Lactobacilli Can Be Helpful in Symptomatic Bacterial Vaginosis: A Randomized Clinical Study. J Low Genit Tract Dis [Internet]. el 1 de julio de 2020 [citado el 5 de febrero de 2024];24(3):284–9. Disponible en: https://journals.lww.com/10.1097/LGT.0000000000000518
Cohen CR, Wierzbicki MR, French AL, Morris S, Newmann S, Reno H, et al. Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis. New England Journal of Medicine [Internet]. el 14 de mayo de 2020 [citado el 5 de febrero de 2024];382(20):1906–15. Disponible en: https://www.nejm.org/doi/10.1056/NEJMoa1915254
Chieng WK, Abdul Jalal MI, Bedi JS, Zainuddin AA, Mokhtar MH, Abu MA, et al. Probiotics, a promising therapy to reduce the recurrence of bacterial vaginosis in women? a systematic review and meta-analysis of randomized controlled trials. Front Nutr [Internet]. el 20 de septiembre de 2022 [citado el 5 de febrero de 2024];9. Disponible en: https://www.frontiersin.org/articles/10.3389/fnut.2022.938838/full
Chen R, Li R, Qing W, Zhang Y, Zhou Z, Hou Y, et al. Probiotics are a good choice for the treatment of bacterial vaginosis: a meta-analysis of randomized controlled trial. Reprod Health [Internet]. el 13 de junio de 2022 [citado el 5 de febrero de 2024];19(1):137. Disponible en: https://reproductive-health-journal.biomedcentral.com/articles/10.1186/s12978-022-01449-z
Wang Z, He Y, Zheng Y. Probiotics for the Treatment of Bacterial Vaginosis: A Meta-Analysis. Int J Environ Res Public Health [Internet]. el 12 de octubre de 2019;16(20):3859. Disponible en: https://www.mdpi.com/1660-4601/16/20/3859
H-F L, N Y. A systematic review and meta-analysis on the efficacy of probiotics for bacterial vaginosis. Eur Rev Med Pharmacol Sci [Internet]. 2022 [citado el 5 de febrero de 2024]; Disponible en: https://www.europeanreview.org/article/27752
Qi F, Fan S, Fang C, Ge L, Lyu J, Huang Z, et al. Orally administrated Lactobacillus gasseri TM13 and Lactobacillus crispatus LG55 can restore the vaginal health of patients recovering from bacterial vaginosis. Front Immunol [Internet]. el 27 de julio de 2023 [citado el 5 de febrero de 2024];14. Disponible en: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1125239/full
Mändar R, Sõerunurk G, Štšepetova J, Smidt I, Rööp T, Kõljalg S, et al. Impact of Lactobacillus crispatus-containing oral and vaginal probiotics on vaginal health: a randomised double-blind placebo controlled clinical trial. Benef Microbes [Internet]. el 14 de abril de 2023 [citado el 5 de febrero de 2024];14(2):143–52. Disponible en: https://brill.com/view/journals/bm/14/2/article-p143_5.xml
Elsharkawy I, Noureldin E, Mohamed E, Mohamed A, Abdeldayem H, Mansour SAM. Continuous versus interrupted use of vaginal probiotics plus vaginal clindamycin cream for bacterial vaginosis: a randomized controlled study. The Journal of Maternal-Fetal & Neonatal Medicine [Internet]. el 2 de enero de 2021 [citado el 5 de febrero de 2024];34(1):58–65. Disponible en: https://www.tandfonline.com/doi/full/10.1080/14767058.2019.1588246
Nurainiwati SA, Ma’roef M, Pravitasari DN, Putra PYP. Effectivity and efficacy probiotics for Bacterial Vaginosis treatments: Meta-analysis. Infect Dis Model [Internet]. diciembre de 2022 [citado el 5 de febrero de 2024];7(4):597–604. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S2468042722000689
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 LA CIENCIA AL SERVICIO DE LA SALUD Y NUTRICIÓN
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
